4D Molecular Therapeutics, Inc. Q1 FY2026 Earnings Call

4D Molecular Therapeutics, Inc. (FDMT)

Earnings Call FY2026 Q1 Call date: 2026-05-07 NoCallHeld

Quarter scorecard

Revenue

$3.05M

+21664.3% YoY

Diluted EPS

$-1.01

Net income

-$68.76M

Japan $2.96M

United States $90,000

+542.9%